SE8804003D0 - Compounds for the treatment of urinary incontinence - Google Patents

Compounds for the treatment of urinary incontinence

Info

Publication number
SE8804003D0
SE8804003D0 SE8804003A SE8804003A SE8804003D0 SE 8804003 D0 SE8804003 D0 SE 8804003D0 SE 8804003 A SE8804003 A SE 8804003A SE 8804003 A SE8804003 A SE 8804003A SE 8804003 D0 SE8804003 D0 SE 8804003D0
Authority
SE
Sweden
Prior art keywords
lower alkyl
compounds
treatment
hydroxy
hydrogen
Prior art date
Application number
SE8804003A
Other languages
English (en)
Swedish (sv)
Inventor
C H *Sjoegren B
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of SE8804003D0 publication Critical patent/SE8804003D0/xx
Priority to SE8804003A priority Critical patent/SE8804003D0/xx
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to EP89119480A priority patent/EP0367040B1/en
Priority to IE339889A priority patent/IE63480B1/en
Priority to DE68906122T priority patent/DE68906122T2/de
Priority to ES89119480T priority patent/ES2054980T3/es
Priority to AT89119480T priority patent/ATE88460T1/de
Priority to CA002001641A priority patent/CA2001641A1/en
Priority to DK544689A priority patent/DK544689A/da
Priority to HU895648A priority patent/HU202828B/hu
Priority to JP1285092A priority patent/JPH02218652A/ja
Priority to NZ231243A priority patent/NZ231243A/en
Priority to DD89334233A priority patent/DD289467A5/de
Priority to FI895229A priority patent/FI895229A0/fi
Priority to PH39454A priority patent/PH27014A/en
Priority to AU44394/89A priority patent/AU628879B2/en
Priority to SU894742370A priority patent/RU1833370C/ru
Priority to ZA898385A priority patent/ZA898385B/xx
Priority to NO89894384A priority patent/NO894384L/no
Priority to PT92189A priority patent/PT92189B/pt
Priority to KR1019890016004A priority patent/KR900007407A/ko
Priority to CN89109190A priority patent/CN1043700A/zh
Priority to TW078109850A priority patent/TW197944B/zh
Priority to US07/771,813 priority patent/US5236956A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
SE8804003A 1988-11-04 1988-11-04 Compounds for the treatment of urinary incontinence SE8804003D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE8804003A SE8804003D0 (sv) 1988-11-04 1988-11-04 Compounds for the treatment of urinary incontinence
AT89119480T ATE88460T1 (de) 1988-11-04 1989-10-20 Verbindungen zur behandlung von harninkontinenz.
ES89119480T ES2054980T3 (es) 1988-11-04 1989-10-20 Compuestos para el tratamiento de la incontinencia urinaria.
IE339889A IE63480B1 (en) 1988-11-04 1989-10-20 Compounds for the treatment of urinary incontinence
DE68906122T DE68906122T2 (de) 1988-11-04 1989-10-20 Verbindungen zur Behandlung von Harninkontinenz.
EP89119480A EP0367040B1 (en) 1988-11-04 1989-10-20 Compounds for the treatment of urinary incontinence
CA002001641A CA2001641A1 (en) 1988-11-04 1989-10-27 Compounds for the treatment of urinary incontinence
DK544689A DK544689A (da) 1988-11-04 1989-11-01 Forbindelser til behandling af urininkontinens
HU895648A HU202828B (en) 1988-11-04 1989-11-02 Process for producing n,n-disubstituted diaryl-alkan-carboxylic amide derivatives and pharmaceutical compositions containing them as active components
JP1285092A JPH02218652A (ja) 1988-11-04 1989-11-02 尿失禁治療のための化合物
NZ231243A NZ231243A (en) 1988-11-04 1989-11-02 Diphenylalkylamide derivatives and pharmaceutical compositions thereof
DD89334233A DD289467A5 (de) 1988-11-04 1989-11-03 Verbindungen zur behandlung von harninkontinenz
PT92189A PT92189B (pt) 1988-11-04 1989-11-03 Processo para a preparacao de derivados de difenilacetamidas e de composicoes farmaceuticas que os contem
FI895229A FI895229A0 (fi) 1988-11-04 1989-11-03 Foereningar foer behandling av urininkontinens och framstaellning daerav.
PH39454A PH27014A (en) 1988-11-04 1989-11-03 Compounds for the treatment of urinary incontinence
AU44394/89A AU628879B2 (en) 1988-11-04 1989-11-03 Compounds for the treatment of urinary incontinence
SU894742370A RU1833370C (en) 1988-11-04 1989-11-03 Method of synthesis of amidocompounds or their physiologically acceptable salts, or their optical isomers, or their mixtures or separate enantiomers
ZA898385A ZA898385B (en) 1988-11-04 1989-11-03 Compounds for the treatment of urinary incontinence
NO89894384A NO894384L (no) 1988-11-04 1989-11-03 Forbindelser for behandling av urininkontinens.
KR1019890016004A KR900007407A (ko) 1988-11-04 1989-11-04 방광질환 치료에 사용하기 위한 화합물 및 방광 질환의 치료 방법
CN89109190A CN1043700A (zh) 1988-11-04 1989-11-04 用于治疗尿失禁的化合物
TW078109850A TW197944B (zh) 1988-11-04 1989-12-19
US07/771,813 US5236956A (en) 1988-11-04 1991-10-07 Compounds for the treatment of urinary incontinence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8804003A SE8804003D0 (sv) 1988-11-04 1988-11-04 Compounds for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
SE8804003D0 true SE8804003D0 (sv) 1988-11-04

Family

ID=20373858

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8804003A SE8804003D0 (sv) 1988-11-04 1988-11-04 Compounds for the treatment of urinary incontinence

Country Status (22)

Country Link
EP (1) EP0367040B1 (zh)
JP (1) JPH02218652A (zh)
KR (1) KR900007407A (zh)
CN (1) CN1043700A (zh)
AT (1) ATE88460T1 (zh)
AU (1) AU628879B2 (zh)
CA (1) CA2001641A1 (zh)
DD (1) DD289467A5 (zh)
DE (1) DE68906122T2 (zh)
DK (1) DK544689A (zh)
ES (1) ES2054980T3 (zh)
FI (1) FI895229A0 (zh)
HU (1) HU202828B (zh)
IE (1) IE63480B1 (zh)
NO (1) NO894384L (zh)
NZ (1) NZ231243A (zh)
PH (1) PH27014A (zh)
PT (1) PT92189B (zh)
RU (1) RU1833370C (zh)
SE (1) SE8804003D0 (zh)
TW (1) TW197944B (zh)
ZA (1) ZA898385B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192779A (en) * 1989-02-14 1993-03-09 Fujisawa Pharmaceutical Co., Ltd. Substituted-acetamide compound and a process for the preparation thereof
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof
AU642582B2 (en) * 1991-02-25 1993-10-21 Eli Lilly And Company Treatment of lower urinary tract disorders
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
GB0328060D0 (en) * 2003-12-04 2004-01-07 Sod Conseils Rech Applic Botulinum toxin treatment
MX368097B (es) * 2015-04-28 2019-09-19 Unilever Nv Compuestos de n-aralquilcarbonildiamina y composiciones para el cuidado personal que comprende los mismos.
CN107531655B (zh) 2015-04-28 2021-03-12 荷兰联合利华有限公司 N-芳烷基羰基-哌嗪和n-芳烷基羰基-高哌嗪化合物以及包含它们的个人护理组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009144A (en) * 1935-07-23 Substituted amides of amphatic-
US2831892A (en) * 1956-03-22 1958-04-22 Searle & Co N-(3-isopropylaminopropyl) diphenyl-acetamide and processes
FR2319337A1 (fr) * 1975-07-30 1977-02-25 Fabre Sa Pierre Gem diaryles possedant une activite antiarythmique utile en therapeutique cardiovasculaire
FR2333501A2 (fr) * 1975-12-03 1977-07-01 Science Union & Cie Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2340724A2 (fr) * 1976-02-13 1977-09-09 Science Union & Cie Nouveaux diarylacetamides substitues, leurs procedes de preparation et les compositions pharmaceutiques en contenant
FR2421892A1 (fr) * 1977-10-17 1979-11-02 Fabre Sa Pierre Procede de synthese industrielle du n(n' ethyl pyrrolidino-2 methyl) aadiphenylahydroxy acetamide
FR2421891A1 (fr) * 1977-10-17 1979-11-02 Fabre Sa Pierre Obtention industrielle d'amides de la pyrrolidine ethyl amine
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof

Also Published As

Publication number Publication date
HU895648D0 (en) 1990-01-28
PT92189A (pt) 1990-05-31
HU202828B (en) 1991-04-29
ZA898385B (en) 1990-07-25
JPH02218652A (ja) 1990-08-31
CA2001641A1 (en) 1990-05-04
NO894384D0 (no) 1989-11-03
NO894384L (no) 1990-05-07
PT92189B (pt) 1995-07-18
IE63480B1 (en) 1995-05-03
EP0367040A1 (en) 1990-05-09
DK544689D0 (da) 1989-11-01
DE68906122T2 (de) 1997-05-22
ATE88460T1 (de) 1993-05-15
IE893398L (en) 1990-05-04
AU628879B2 (en) 1992-09-24
NZ231243A (en) 1994-03-25
ES2054980T3 (es) 1994-08-16
RU1833370C (en) 1993-08-07
TW197944B (zh) 1993-01-11
EP0367040B1 (en) 1993-04-21
DD289467A5 (de) 1991-05-02
PH27014A (en) 1993-02-01
AU4439489A (en) 1990-05-10
KR900007407A (ko) 1990-06-01
FI895229A0 (fi) 1989-11-03
DE68906122D1 (de) 1993-05-27
HUT51597A (en) 1990-05-28
DK544689A (da) 1990-05-05
CN1043700A (zh) 1990-07-11

Similar Documents

Publication Publication Date Title
SE9701144D0 (sv) Novel compounds, their use and preparation
DE69409913T2 (de) Methode zur Hemmung der Proliferation weiche Muskelzellen und der Restenose
ATE205206T1 (de) Benzylidenthiazolidinderivate, ihre herstellung und ihre anwendung als lipidperoxid-inhibitoren
ATE106885T1 (de) Substituierte harnstoffverbindungen, ihre herstellung und verwendung.
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
SE8804003D0 (sv) Compounds for the treatment of urinary incontinence
NO942568L (no) 1-aryloksy-3-alkylamino-2-propanolnitratestere, deres anvendelse og tilsvarende farmasöytiske blanding
SE0104333D0 (sv) Therapeutic agents
ES2088903T3 (es) Nuevos inhibidores de la s-adenosilmetionina descarboxilasa.
DE3675431D1 (de) 1,3-oxathianderivate.
ATE63899T1 (de) 8-(niederalkyl)bicyclo(4.2.0>octanderivate mit wertvollen therapeutischen eigenschaften.
PL364794A1 (en) 2-aminotetralin derivatives for the therapy of glaucoma